A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (5) , S269-S273
- https://doi.org/10.1016/0002-9343(89)90078-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patientsJournal of Antimicrobial Chemotherapy, 1988
- Intravenous ciprofloxacin in the treatment of infection in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1986
- Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patientsJournal of Antimicrobial Chemotherapy, 1986
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Is there a role for monotherapy with -lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?Journal of Antimicrobial Chemotherapy, 1986
- A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patientsAntimicrobial Agents and Chemotherapy, 1985
- Ceftazidime as first-line therapy for fever in acute leukaemiaJournal of Infection, 1985
- SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIAThe Lancet, 1983
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971